These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 16893403)

  • 1. Erythropoietin resistance in the treatment of the anemia of chronic renal failure.
    Priyadarshi A; Shapiro JI
    Semin Dial; 2006; 19(4):273-8. PubMed ID: 16893403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anemia in renal insufficiency.
    Santoro A
    Rev Clin Exp Hematol; 2002; Suppl 1():12-20. PubMed ID: 12735211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of anemia in patients with chronic renal insufficiency with recombinant human erythropoietin].
    Djukanović Lj; Lezaić V
    Srp Arh Celok Lek; 1996; 124(3-4):93-7. PubMed ID: 9102827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unusual etiology of erythropoietin resistance: hyperthyroidism.
    Kaynar K; Ozkan G; Erem C; Gul S; Yilmaz M; Sonmez B; Ozdemir F; Ulusoy S
    Ren Fail; 2007; 29(6):759-61. PubMed ID: 17763175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What are the aims and targets of renal anemia therapy?].
    Eckardt KU
    Dtsch Med Wochenschr; 2007 Sep; 132(36):1837-41. PubMed ID: 17726657
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythropoietin-resistant refractory renal anemia: effects of oral L-carnitine supplementation.
    Kawabata M; Kasuga S; Hara H; Suyama S; Moriyama K; Takabatake T
    Clin Nephrol; 2001 Mar; 55(3):265-6. PubMed ID: 11316253
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anemia of end-stage renal disease (ESRD)].
    Osaka N; Kawaguchi Y
    Ryoikibetsu Shokogun Shirizu; 1997; (17 Pt 2):58-61. PubMed ID: 9277860
    [No Abstract]   [Full Text] [Related]  

  • 8. Iron supplementation in renal anemia.
    Fishbane S
    Semin Nephrol; 2006 Jul; 26(4):319-24. PubMed ID: 16949471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Requirement for blood in hemodialyzed patients with chronic renal failure in the period before and after introduction to erythropoietin (r-HuEPO) treatment].
    Wiecek A; Kokot F; Spiechowicz U; Cieplok J; Czerwieńska B; Strzelczyk P; Dyjas R
    Przegl Lek; 1996; 53(12):866-9. PubMed ID: 9163010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin and its use in renal failure.
    Sulková S; Krajhanzl A
    EDTNA ERCA J; 1996; 22(1):suppl 1-7; quiz 8. PubMed ID: 10723310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in haemodialysis patients.
    Costa E; Swinkels DW; Laarakkers CM; Rocha-Pereira P; Rocha S; Reis F; Teixeira F; Miranda V; do Sameiro Faria M; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
    Acta Haematol; 2009; 122(4):226-9. PubMed ID: 19887781
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonhematologic complications of erythropoietin therapy.
    Zhu X; Perazella MA
    Semin Dial; 2006; 19(4):279-84. PubMed ID: 16893404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Appropriate iron supplementation in renal anemia treatment].
    Suzuki M
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():566-8. PubMed ID: 15250370
    [No Abstract]   [Full Text] [Related]  

  • 14. DMT1 (NRAMP2/DCT1) genetic variability and resistance to recombinant human erythropoietin therapy in chronic kidney disease patients under haemodialysis.
    Costa E; Rocha S; Rocha-Pereira P; Reis F; Castro E; Teixeira F; Miranda V; do Sameiro Faria M; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
    Acta Haematol; 2008; 120(1):11-3. PubMed ID: 18667808
    [No Abstract]   [Full Text] [Related]  

  • 15. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of human recombinant erythropoietin (rHuEPO) for treatment of anemia in patients with chronic kidney failure who don't require additional dialysis therapy].
    Wiecek A
    Przegl Lek; 1995; 52(3):93-4. PubMed ID: 7644683
    [No Abstract]   [Full Text] [Related]  

  • 17. Anemia management in chronic kidney disease: what have we learned after 17 years?
    Spiegel DM
    Semin Dial; 2006; 19(4):269-72. PubMed ID: 16893402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anemia syndrome in patients with chronic renal insufficiency on peritoneal dialysis treated with recombinant erythropoietin].
    Romanova LA; Lugovskaia SA; Khareb F; Shumov EV; Shmarov DA
    Urologiia; 2002; (5):26-30. PubMed ID: 12402772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does early anemia correction prevent complications of chronic renal failure?
    Drüeke TB; Eckardt KU; Frei U; Jacobs C; Kokot F; McMahon LP; Schaefer RM
    Clin Nephrol; 1999 Jan; 51(1):1-11. PubMed ID: 9988140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of iron in patients on chronic dialysis: mistake and misconceptions.
    Sakiewicz P; Paganini E
    J Nephrol; 1998; 11(1):5-15. PubMed ID: 9561479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.